| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DYNAVAX TECHNOLOGIES CORP | 1,019,491 | 6,066,000 | 0.39% | ||
| 52 | SURGERY PARTNERS INCORPORATED | 303,500 | 5,918,000 | 0.38% | ||
| 53 | AVEXIS INC COM | 45,349 | 3,448,000 | 0.22% | ||
| 54 | ACLARIS THERAPEUTICS INC COM | 90,700 | 2,705,000 | 0.18% | ||
| 55 | RA PHARMACEUTICALS INC COM | 110,769 | 2,358,000 | 0.15% | ||
| 56 | AURINIA PHARMACEUTICALS INC | 140,243 | 1,029,000 | 0.07% | ||
| 57 | UNITEDHEALTH GROUP INC | 1,820 | 298,000 | 0.02% | ||
| 58 | AMEDISYS INC COM | 4,826 | 247,000 | 0.02% | ||
| 59 | ADVERUM BIOTECHNOLOGIES INC | 22,236 | 60,000 | 0.00% | ||
| 60 | CASTLIGHT HEALTH INC COM CL B | 10,229 | 37,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-17-000012, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
